49
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Targeting antioxidants to mitochondria by conjugation to lipophilic cations.

      1 ,
      Annual review of pharmacology and toxicology
      Annual Reviews

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Mitochondrial oxidative damage contributes to a range of degenerative diseases. Consequently, the selective inhibition of mitochondrial oxidative damage is a promising therapeutic strategy. One way to do this is to invent antioxidants that are selectively accumulated into mitochondria within patients. Such mitochondria-targeted antioxidants have been developed by conjugating the lipophilic triphenylphosphonium cation to an antioxidant moiety, such as ubiquinol or alpha-tocopherol. These compounds pass easily through all biological membranes, including the blood-brain barrier, and into muscle cells and thus reach those tissues most affected by mitochondrial oxidative damage. Furthermore, because of their positive charge they are accumulated several-hundredfold within mitochondria driven by the membrane potential, enhancing the protection of mitochondria from oxidative damage. These compounds protect mitochondria from damage following oral delivery and may therefore form the basis for mitochondria-protective therapies. Here we review the background and work to date on this class of mitochondria-targeted antioxidants.

          Related collections

          Author and article information

          Journal
          Annu Rev Pharmacol Toxicol
          Annual review of pharmacology and toxicology
          Annual Reviews
          0362-1642
          0362-1642
          2007
          : 47
          Affiliations
          [1 ] MRC Dunn Human Nutrition Unit, Wellcome Trust/MRC Building, Cambridge CB2 2XY, United Kingdom. mpm@mrc-dunn.cam.ac.uk
          Article
          10.1146/annurev.pharmtox.47.120505.105110
          17014364
          4dcfeae1-1ef2-48f8-8e08-4687f7ea98c6
          History

          Comments

          Comment on this article